LB Pharmaceuticals Quarterly Cash Flow Statement
NASDAQ: LBRXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
37.22+2.61 (+7.54%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
LB Pharmaceuticals free cash flow
In the quarter ended Jun 30, 2026, LB Pharmaceuticals generated -$37.6 million of operating cash flow and spent $363,000 on capital expenditures. That left free cash flow of -$38.0 million.
Summary generated from market data by MetaCap's automated system. Methodology
LB Pharmaceuticals cash flow statement (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -51.60M | -19.05M | -11.47M | -3.56M | -4.87M | -5.31M | -5.07M | -14.18M | -27.63M | -16.22M |
| Net Income growth (YoY) | — | — | — | — | — | — | — | — | — | — |
| Depreciation & Amortization | 97.00K | 82.00K | — | 81.00K | 76.00K | 79.00K | — | — | — | — |
| Stock-Based Compensation | 4.90M | 2.57M | 2.34M | 881.00K | 335.00K | 634.00K | 2.28M | — | — | — |
| Change in Working Capital | 8.47M | -6.75M | -9.33M | 205.00K | -1.31M | -2.81M | -2.92M | — | — | — |
| Operating Cash Flow | -37.63M | -23.29M | -18.10M | -3.37M | -5.60M | -8.13M | -5.67M | — | — | — |
| Capital Expenditures | -363.00K | -32.00K | -40.00K | 0 | 9.00K | -21.00K | -238.00K | — | — | — |
| Investing Cash Flow | 89.00K | -32.00K | -40.00K | -44.84M | 9.00K | 4.98M | 13.54M | — | — | — |
| Financing Cash Flow | -19.00K | 93.83M | -1.17M | 303.73M | 0 | 0 | 0 | — | — | — |
| Net Change in Cash | -37.56M | 70.51M | -19.31M | 255.52M | -5.59M | -3.15M | 7.87M | — | — | — |
| Free Cash Flow | -37.99M | -23.32M | -18.14M | -3.37M | -5.59M | -8.15M | -5.90M | — | — | — |
This table shows 10 quarterly periods of LB Pharmaceuticals's cash flow statement, from Q2 2026 back to Q1 2024, across 10 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow LBRX's reporting calendar. What is a cash flow statement?